Certified by Founder
Lodge
Myeloid Therapeutics
start up
United States
- Cambridge, Massachusetts
- 19/05/2023
- Unknown
- $73,000,000
At Myeloid, we have applied our extensive knowledge of advanced gene and cell therapies to build novel platform technologies that harness the innate abilities of myeloid cells. We have translated the learnings from our backgrounds and novel platform to create a clinical-stage, mRNA-immunotherapy pipeline focused on breakthrough therapies for cancer.
We invite you to join us on this journey – patients are waiting.
- Industry Biotechnology
- Website https://myeloidtx.com/
- LinkedIn https://www.linkedin.com/company/myeloidtx/
Related People
Daniel G.Co Founder
United States -
Greater Boston
Dr Getts is a repeat inventor, company co-founder and builder. He is currently the Chief Executive Officer & co-founder of Myeloid Therapeutics Inc .
Iceotope | $26,000,000 | (May 15, 2026)
Harken Sweets | Undisclosed Amount | (May 15, 2026)
Graphon AI | $8,300,000 | (May 15, 2026)
Ranger AI | $8,400,000 | (May 15, 2026)
Wirestock | $23,000,000 | (May 15, 2026)
GridCARE | $64,000,000 | (May 15, 2026)
Chromie Health | $2,000,000 | (May 15, 2026)
Novella | $21,000,000 | (May 15, 2026)
Flick | $6,000,000 | (May 15, 2026)
Synthetic | $10,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Urologic Health | $11,000,000 | (May 14, 2026)